Adventures in Hepatocarcinogenesis

Literature Cited

1. Dechary JM, Kun E, Pitot HC. 1954. Spectrophotometric determination of ethanediol. Anal. Chem. 26:449 [Google Scholar]
2. Kun E, Dechary JM, Pitot HC. 1954. The oxidation of glycolic acid by a liver enzyme. J. Biol. Chem. 210:269 [Google Scholar]
3. Gale EF, Folkes JP. 1955. The assimilation of amino acids by bacteria. 20. The incorporation of labeled amino acids by disrupted staphylococcal cells. Biochem. J. 59:661–75 [Google Scholar]
4. Pitot HC. 1959. Studies on the control of protein synthesis in normal and neoplastic rat liver. PhD thesis. Tulane Univ.:193 pp.
5. Dunning WF, Curtis MR, Mann ME. 1950. The effect of added dietary tryptophan on the occurrence of 2-acetylaminofluorene-induced liver and bladder cancer in rats. Cancer Res. 10:454–59 [Google Scholar]
6. Novikoff AB. 1957. A transplantable rat liver tumor induced by 4-dimethylamino-azobenzene. Cancer Res. 17:1010–27 [Google Scholar]
7. Pitot HC. 1955. The in vitro synthesis of protein. Bull. Tulane Univ. Med. Fac. 14:165 [Google Scholar]
8. Pitot HC. 1959. Metabolic adaptations and the neoplastic cell. Bull. Tulane Univ. Med. Fac. 19:17 [Google Scholar]
9. Pitot HC, Potter VR. 1960. An enzymatic study on the cellular origin of the Dunning and the Novikoff hepatomas in the rat. Biochim. Biophys. Acta 40:537–39 [Google Scholar]
10. Morris HP. 1965. Studies on the development, biochemistry and biology of experimental hepatomas. Adv. Cancer Res. 9:227–302 [Google Scholar]
11. Potter VR. 1958. The biochemical approach to the cancer problem. Fed. Proc. 17:691–97 [Google Scholar]
12. Pitot HC. 1960. The comparative enzymology and cell origin of rat hepatomas. II. Glutamate dehydrogenase, choline oxidase, and glucose-6-phosphatase. Cancer Res. 20:1262–68 [Google Scholar]
13. Pitot HC, Morris HP. 1961. Metabolic adaptations in rat hepatomas. II. Tryptophan pyrrolase and tyrosine α-ketoglutarate transaminase. Cancer Res. 21:1009–14 [Google Scholar]
14. Pitot HC, Potter VR, Morris HP. 1961. Metabolic adaptations in rat hepatomas. I. The effect of dietary protein on some inducible enzymes in liver and hepatoma 5123. Cancer Res. 21:1001–8 [Google Scholar]
15. Bottomley RH, Pitot HC, Morris HP. 1963. Metabolic adaptations in rat hepatomas. IV. Regulation of threonine and serine dehydrase. Cancer Res. 23:392–99 [Google Scholar]
16. Potter VR. 1964. Biochemical perspectives in cancer research. Cancer Res. 24:1085–98 [Google Scholar]
17. Potter VR. 1964. Biochemical studies on Minimal Deviation hepatomas. In Cellular Control Mechanisms and Cancer ed. O Mühlbock, P Emmelot pp. 190–210 Amsterdam: Elsevier [Google Scholar]
18. Pitot HC, Heidelberger C. 1963. Metabolic regulatory circuits and carcinogenesis. Cancer Res. 23:1694–1700 [Google Scholar]
19. Pitot HC. 1962. Molecular pathogenesis of experimental liver cancer. Fed. Proc. 21:1124–29 [Google Scholar]
20. Pitot HC, Peraino C. 1963. Carbohydrate repression of enzyme induction in rat liver. J. Biol. Chem. 238:1910–12 [Google Scholar]
21. Peraino C, Pitot HC. 1964. Studies on the induction and repression of enzymes in rat liver. II. Carbohydrate repression of dietary and hormonal induction of threonine dehydrase and ornithine-δ-transaminase. J. Biol. Chem. 239:4308–14 [Google Scholar]
22. Weber G. 1983. Biochemical strategy of cancer cells and the design of chemotherapy: G.H.A. Clowes Memorial Lecture. Cancer Res. 43:3466–92 [Google Scholar]
23. Adelman RC, Morris HP, Weinhouse S. 1967. Fructokinase, triokinase, and aldolases in liver tumors of the rat. Cancer Res. 27:2408–13 [Google Scholar]
24. Sugimura T, Ikeda K, Hirota K, Hozumi M, Morris HP. 1966. Chemical, enzymatic, and cytochrome assays of microsomal fraction of hepatomas with different growth rates. Cancer Res. 26:1711–16 [Google Scholar]
25. Lea MA. 1993. Regulation of gene expression in hepatomas. Int. J. Biochem. 25:457–69 [Google Scholar]
26. Cote GJ, Chiu JF. 1987. The expressions of oncogenes and liver-specific genes in Morris hepatomas. Biochem. Biophys. Res. Commun. 143:624–29 [Google Scholar]
27. Siddiqui B, Hakomori S. 1970. Change of glycolipid pattern in Morris hepatomas 5123 and 7800. Cancer Res. 30:2930–36 [Google Scholar]
28. Pitot HC. 1978. The language of oncology: the definition of neoplasia. In Fundamentals of Oncology pp. 15–28 New York: Marcel Dekker, Inc.192 pp. , 1st ed.. [Google Scholar]
29. Traut RR, Monro RE. 1964. The puromycin reaction and its relation to protein synthesis. J. Mol. Biol. 10:63–72 [Google Scholar]
30. Reich E, Franklin RM, Shatkin AJ, Tatum EL. 1962. Action of actinomycin D on animal cells and viruses. Proc. Natl. Acad. Sci. USA 48:1238–45 [Google Scholar]
31. Pitot HC, Cho YS. 1965. Control mechanisms in the normal and neoplastic cell. Prog. Exp. Tumor Res. 7:158–223 [Google Scholar]
32. Pitot HC, Peraino C, Lamar C Jr, Kennan AL. 1965. Template stability of some enzymes in rat liver and hepatoma. Proc. Natl. Acad. Sci. USA 54:845–51Induction of serine dehydratase was insensitive to actinomycin D administration for 6–8 hours in liver, but for more than two weeks in the Morris 5123 hepatoma. [Google Scholar]
33. Pitot HC, Sladek N, Ragland W, Murray RK, Moyer G. et al. 1969. Possible role of the endoplasmic reticulum in the regulation of genetic expression: the membron concept. In Microsomes and Drug Oxidations ed. JR Gillette, AH Conney, GJ Cosmides, RW Estabrook, JR Fouts, GJ Mannering pp. 59–80 New York: Academic [Google Scholar]
34. Lamar CJ, Prival M, Pitot HC. 1966. Studies on the mechanism of template stability. I. The effect of actinomycin on the base composition and sedimentation of ³²P-labeled RNA in rat liver. Cancer Res. 23:1909–14 [Google Scholar]
35. Sladek NE, Pitot HC. 1970. Studies on the mechanism of template stability: cytoplasmic DNA-like RNA in hepatocellular carcinomas. Cancer Res. 30:1598–1604 [Google Scholar]
36. Sidransky H, Verney E, Murty CN. 1979. Stability of messenger ribonucleic acid of free and membrane-bound polyribosomes of the livers of rats treated with ethionine. Lab. Invest. 40:92–98 [Google Scholar]
37. Belanger FC, Brodl MR, Ho TD. 1986. Heat shock causes destabilization of specific mRNAs and destruction of endoplasmic reticulum in barley aleurone cells. Proc. Natl. Acad. Sci. USA 83:1354–58 [Google Scholar]
38. Shires TK, Pitot HC, Kauffmann S. 1974. The membron: a functional hypothesis for the translational regulation of genetic expression. Biomembranes 5:81 [Google Scholar]
39. Suss R, Blobel G, Pitot HC. 1966. Rat liver and hepatoma polysome-membrane interaction in vitro. Biochem. Biophys. Res. Commun. 23:229–304 [Google Scholar]
40. Pitot HC. 1968. Template stability: its mechanism in liver and its aberrations in hepatomas. Gann Monogr. 4:175–82 [Google Scholar]
41. Yatvin MB, Pitot HC. 1970. Action of actinomycin D on tryptophan uptake in the adrenalectomized rat and its effect on induction of tryptophan pyrrolase and tyrosine transaminase in liver. J. Biol. Chem. 245:4673–76 [Google Scholar]
42. Bader M, Thrum H, Güttner J, Klinger W. 1974. Actinomycin D: toxicity, liver functions and morphological findings in rats. Acta Biol. Med. Germ. 32:91–98 [Google Scholar]
43. Hofert J, Gorski J, Mueller GC, Boutwell RK. 1962. The depletion of liver glycogen in puromycin-treated animals. Arch. Biochem. Biophys. 97:134–37 [Google Scholar]
44. Jost JP, Khairallah EA, Pitot HC. 1968. Studies on the induction and repression of enzymes in rat liver. V. Regulation of the rate of synthesis and degradation of serine dehydratase by dietary amino acids and glucose. J. Biol. Chem. 243:3057–66 [Google Scholar]
45. Jost JP, Pitot HC. 1970. Metabolic adaptations in rat hepatomas: altered regulation of serine dehydratase synthesis by glucose and amino acids in hepatocellular carcinomas. Cancer Res. 30:387–92 [Google Scholar]
46. Bottomley RH, Pitot HC, Potter VR, Morris HP. 1964. Metabolic adaptations in rat hepatomas. V. Reciprocal relationship between threonine dehydrase and glucose-6-phosphate dehydrogenase. Cancer Res. 32:400–9 [Google Scholar]
47. Peraino C, Lamar CJ, Pitot HC. 1966. Studies on the induction and repression of enzymes in rat liver. VI. Effects of cortisone and phenobarbital. J. Biol. Chem. 241:2944–48 [Google Scholar]
48. Khairallah EA, Pitot HC. 1968. Studies on the turnover of serine dehydratase: amino acid induction, glucose repression and pyridoxine stabilization. In Symposium on Pyridoxal Enzymes ed. K Yamada, N Katunuma, H Wada pp. 159–64 Tokyo: Maruzen [Google Scholar]
49. Potter VR, Watanabe M, Pitot HC, Morris HP. 1969. Systematic oscillations in metabolic activity in rat liver and hepatomas. Survey of normal diploid and other hepatoma lines. Cancer Res. 29:55–78Dietary regulation of four different enzymes was different and distinct for each of nine hepatocellular carcinomas and for liver. [Google Scholar]
50. Poirier LA, Pitot HC. 1969. Metabolic adaptations during hepatocarcinogenesis. I. Dietary induction of some enzymes of amino acid metabolism during 2-acetylaminofluorene feeding. Cancer Res. 29:464–69 [Google Scholar]
51. Poirier LA, Poirier MC, Pitot HC. 1969. Metabolic adaptations during hepatocarcinogenesis. II. Dietary induction of some enzymes of carbohydrate and lipid metabolism during 2-acetylaminofluorene feeding. Cancer Res. 29:470–74 [Google Scholar]
52. Poirier LA, Pitot HC. 1969. Metabolic adaptations during hepatocarcinogenesis. III. Dietary induction of some enzymes of amino acid metabolism during azo dye feeding. Cancer Res. 29:475–80 [Google Scholar]
53. Poirier LA, Pitot HC. 1970. Metabolic adaptations during hepatocarcinogenesis: dietary induction of some enzymes of carbohydrate metabolism during 3′methyl- and 2′methyl-N,N-dimethyl-4-aminoazobenzene feeding. Cancer Res. 30:1974–79 [Google Scholar]
54. Pitot HC, Pries N. 1964. The automated assay of complete enzyme reaction rates. I. Methods and results. Anal. Biochem. 9:454–66 [Google Scholar]
55. Pitot HC, Wratten N, Poirier M. 1968. The automated assay of complete enzyme reaction rates. II. Digital readout and data processing of linear rates. Anal. Biochem. 22:359–73 [Google Scholar]
56. Li Y, Li Y, Tang R, Xu H, Qiu M. et al. 2002. Discovery and analysis of hepatocellular carcinoma genes using cDNA microarrays. J. Cancer Res. Clin. Oncol. 128:369–79 [Google Scholar]
57. Schmidt U, Begley CG. 2003. Cancer diagnosis and microarrays. Int. J. Biochem. Cell Biol. 35:119–24 [Google Scholar]
58. Jazaeri AA, Yee CJ, Sotiriou C, Brantley KR, Boyd J, Liu ET. 2002. Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers. J. Natl. Cancer Inst. 94:990–1000 [Google Scholar]
59. Benke PJ, Herrick N, Pitot HC. 1971. Studies on basic charged molecules and cell membranes in cystic fibrosis. Proc. Soc. Exp. Biol. Med. 137:1283–88 [Google Scholar]
60. Quissell DO, Pitot HC. 1974. The number of ouabain-binding sites in fibroblasts from normal subjects and patients with cystic fibrosis. Nature 247:115–16 [Google Scholar]
61. Changus JE, Quissell DO, Sukup MR, Pitot HC. 1975. Studies on the synthesis of plasma membrane proteins of fibroblasts from patients with cystic fibrosis. Am. J. Pathol. 80:317–28 [Google Scholar]
62. Changus JE, Pitot HC. 1976. Cystic fibrosis: a dilemma in the metabolic pathogenesis of genetic disease. Arch. Pathol. Lab. Med. 100:7–11 [Google Scholar]
63. Gahl WA, Chesney J, Pitot HC. 1978. Serum ribonuclease levels in patients with cystic fibrosis. Biochem. Med. 19:294–97 [Google Scholar]
64. Gahl WA, Pitot HC. 1978. Reversal by aminoguanidine of the inhibition of proliferation of human fibroblasts by spermidine and spermine. Chem. Biol. Interact. 22:91–98 [Google Scholar]
65. Pitot HC. 1975. Metabolic controls and neoplasia. In Cancer ed. FF Becker pp. 121–54 New York: Plenum [Google Scholar]
66. Hilf R, Goldenberg H, Michel I, Carrington MJ, Bell C. et al. 1969. Biochemical characteristics of mammary glands and mammary tumors of rats induced by 3-methylcholanthrene and 7,12-dimethylbenz(a)anthracene. Cancer Res. 29:977–88 [Google Scholar]
67. Dua K, Williams TM, Beretta L. 2001. Translational control of the proteome: relevance to cancer. Proteomics 1:1191–99 [Google Scholar]
68. Jacob F, Monod J. 1961. Genetic regulatory mechanisms in the synthesis of proteins. J. Mol. Biol. 3:318–56 [Google Scholar]
69. Kaempfer ROR, Magasanik B. 1967. Mechanism of β-galactosidase induction in Escherichia coli. J. Mol. Biol. 27:475–94 [Google Scholar]
70. Suzuki T, Varshavsky A. 1999. Degradation signals in the lysine-asparagine sequence space. EMBO J. 18:6017–26 [Google Scholar]
71. Cihak A, Vesely J, Inoue H, Pitot HC. 1972. Effect of 5-azacytidine on dietary and hormone induction of serine dehydratase and tyrosine aminotransferase in rat liver. Biochem. Pharmacol. 21:2545–53 [Google Scholar]
72. Cihak A, Lamar CJ, Pitot HC. 1973. L-tryptophan inhibition of tyrosine aminotransferase degradation in rat liver in vivo. Arch. Biochem. Biophys. 156:188–94 [Google Scholar]
73. Cihak A, Lamar CJ, Pitot HC. 1973. Studies on the mechanism of the stimulation of tyrosine aminotransferase activity in vivo by pyrimidine analogs: the role of enzyme synthesis and degradation. Arch. Biochem. Biophys. 156:176–87 [Google Scholar]
74. Cihak A, Wilkinson D, Pitot HC. 1971. The effect of pyrimidine analogues and tryptophan on enzyme synthesis and degradation in rat liver. Adv. Enzyme Regul. 9:267–90 [Google Scholar]
75. Wilkinson DS, Cihak A, Pitot HC. 1971. Inhibition of ribosomal RNA maturation in rat liver by 5-fluoroorotic acid resulting in the selective labeling of cytoplasmic messenger RNA. J. Biol. Chem. 246:6418–275-fluorotate selectively inhibits ribosomal RNA maturation while selectively labeling cytoplasmic mRNA. [Google Scholar]
76. Weiss JW, Pitot HC. 1974. Inhibition of ribosomal ribonucleic acid maturation by 5-azacytidine and 8-azaguanine in Novikoff hepatoma cells. Arch. Biochem. Biophys. 160:119–29 [Google Scholar]
77. Bosch L, Harbers E, Heidelberger C. 1958. Studies on fluorinated pyrimidines. V. Effects on nucleic acid metabolism in vitro. Cancer Res. 18:335–42 [Google Scholar]
78. Inoue H, Kasper CB, Pitot HC. 1971. Studies on the induction and repression of enzymes in rat liver. VI. Some properties and the metabolic regulation of two isozymic forms of serine dehydratase. J. Biol. Chem. 246:2626–32 [Google Scholar]
79. Iwasaki Y, Lamar C, Danenberg K, Pitot HC. 1973. Studies on the induction and repression of enzymes in rat liver. VII. Characterization and metabolic regulation of multiple forms of tyrosine aminotransferase. Eur. J. Biochem. 34:347–57 [Google Scholar]
80. Rodriguez J, Pitot HC. 1976. Studies on the conversion of multiple forms of tyrosine aminotransferase in rat liver. Arch. Biochem. Biophys. 177:185–95 [Google Scholar]
81. Gohda E, Pitot HC. 1980. Purification and characterization of a factor catalyzing the conversion of the multiple forms of tyrosine aminotransferase from rat liver. J. Biol. Chem. 255:7371–79 [Google Scholar]
82. Gohda E, Pitot HC. 1981. A new thiol proteinase from rat liver. J. Biol. Chem. 256:2567–72 [Google Scholar]
83. Shires TK, Narurkar LM, Pitot HC. 1971. The association in vitro of polyribosomes with ribonuclease-treated derivatives of hepatic rough endoplasmic reticulum. Characteristics of the membrane binding sites and factors influencing association. Biochem. J. 125:67–79 [Google Scholar]
84. Shires TK, McLaughlin CA, Pitot HC. 1975. The selectivity and stoicheiometry of membrane binding sites for polyribosomes, ribosomes and ribosomal subunits in vitro. Biochem. J. 146:513–26 [Google Scholar]
85. Ikehara Y, Pitot HC. 1973. Localization of polysome-bound albumin and serine dehydratase in rat liver cell fractions. J. Cell Biol. 59:28–44Synthesis of rat serum albumin as well as rat liver serine dehydratase occurs predominantly on membrane-bound polysomes. [Google Scholar]
86. Cardelli J, Long B, Pitot HC. 1976. Direct association of messenger RNA labeled in the presence of fluoroorotate with membranes of the endoplasmic reticulum in rat liver. J. Cell Biol. 70:47–58 [Google Scholar]
87. Cardelli J, Pitot HC. 1977. Isolation and characterization of rat liver free and membrane-bound polysomal messenger ribonucleoprotein particles. Biochemistry 16:5127–35 [Google Scholar]
88. Mueckler MM, Pitot HC. 1981. Structure and function of rat liver polysome populations. I. Complexity, frequency distribution, and degree of uniqueness of free and membrane-bound polysomal polyadenylate-containing RNA populations. J. Cell Biol. 90:495–506 [Google Scholar]
89. Mueckler MM, Pitot HC. 1982. Structure and function of rat liver polysome populations. II. Evidence for the existence of discrete subpopulations of membrane-bound polysomes. J. Cell Biol. 94:297–307 [Google Scholar]
90. Mueckler MM, Merrill MJ, Pitot HC. 1983. Translational and pretranslational control of ornithine aminotransferase synthesis in rat liver. J. Biol. Chem. 258:6109–14 [Google Scholar]
91. Mueckler MM, Pitot HC. 1983. Regulation of ornithine aminotransferase mRNA levels in rat kidney by estrogen and thyroid hormone. J. Biol. Chem. 258:1781–84 [Google Scholar]
92. Buckingham ME, Caput D, Cohen A, Whalen RG, Gros F. 1974. The synthesis and stability of cytoplasmic messenger RNA during myoblast differentiation in culture. Proc. Natl. Acad. Sci. USA 71:1466–70 [Google Scholar]
93. Michalopoulos G, Sattler CA, Sattler GL, Pitot HC. 1976. Cytochrome P-450 induction by phenobarbital and 3-methylcholanthrene in primary cultures of hepatocytes. Science 193:907–9 [Google Scholar]
94. Michalopoulos G, Sattler GL, Sattler CA, Pitot HC. 1976. Interaction of chemical carcinogens and drug-metabolizing enzymes in primary cultures of hepatic cells from the rat. Am. J. Pathol. 85:755–72 [Google Scholar]
95. Althaus FR, Pitot HC. 1983. Consequences of altered poly(ADP-ribose) metabolism on hepatocyte functions in vitro. In ADP-Ribosylation, DNA Repair and Cancer ed. M Miwa, et al. pp. 321–31 Tokyo: Jpn. Sci. Soc. [Google Scholar]
96. Althaus FR, Pitot HC. 1983. A rapid technique for the quantitation of DNA-repair synthesis in the hepatocyte/DNA-repair test for chemical carcinogens. Ann. N.Y. Acad. Sci. 407:463–66 [Google Scholar]
97. Sirica AE, Hwang CG, Sattler GL, Pitot HC. 1980. Use of primary cultures of adult rat hepatocytes on collagen gel-nylon mesh to evaluate carcinogen-induced unscheduled DNA synthesis. Cancer Res. 40:3259–67 [Google Scholar]
98. Sirica AE, Richards W, Tsukada Y, Sattler CA, Pitot HC. 1979. Fetal phenotypic expression by adult rat hepatocytes on collagen gel-nylon meshes. Proc. Natl. Acad. Sci. USA 76:283–87 [Google Scholar]
99. Sirica AE, Sattler CA, Cihla HP. 1985. Characterization of a primary bile ductular cell culture from the livers of rats during extrahepatic cholestasis. Am. J. Pathol. 120:67–78 [Google Scholar]
100. Oliver IT, Edwards AM, Pitot HC. 1978. Hormonal regulation of phosphoenolpyruvate carboxykinase in primary cultures of adult rat liver parenchymal cells. Eur. J. Biochem. 87:221–27 [Google Scholar]
101. Sattler CA, Michalopoulos G, Sattler GL, Pitot HC. 1978. Ultrastructure of adult rat hepatocytes cultured on floating collagen membranes. Cancer Res. 38:1539–49 [Google Scholar]
102. Spence JT, Pitot HC. 1979. Hormonal regulation of glucokinase in primary cultures of adult rat hepatocytes. J. Biol. Chem. 254:12331–36 [Google Scholar]
103. Haars LJ, Pitot HC. 1979. α_2u-globulin in the rat: the regulation of the appearance of multiple forms in vivo and in primary cultures of adult hepatocytes. J. Biol. Chem. 254:9401–7 [Google Scholar]
104. Mak WWN, Pitot HC. 1981. Microfilament accumulation and the transport of amino acids and glucose in adult rat hepatocytes cultured on collagen gel/nylon mesh. Biochem. Biophys. Res. Commun. 98:203–10 [Google Scholar]
105. Grosso LE, Pitot HC. 1985. Chromatin structure of the c-myc gene in HL-60 cells during alterations of transcriptional activity. Cancer Res. 45:5035–41 [Google Scholar]
106. Pitot HC, Barsness L, Goldsworthy T, Kitagawa T. 1978. Biochemical characterizations of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine. Nature 271:456–58Initiation by a low single dose of DEN followed by feeding 0.05% phenobarbital results in the development of AHF of multiple phenotypes in rat liver. [Google Scholar]
107. Peraino C, Fry RJM, Staffeldt E. 1977. Effects of varying the onset and duration of exposure to phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis. Cancer Res. 37:3623–27 [Google Scholar]
108. Scherer E, Emmelot P. 1975. Kinetics of induction and growth of precancerous liver-cell foci, and liver tumor formation by diethylnitrosamine in the rat. Eur. J. Cancer 11:689–96 [Google Scholar]
109. Gössner VW, Friedrich-Freksa H. 1964. Histochemische untersuchungen über die glucose-6-phosphatase in der rattenleber während der kanzerisierung durch nitrosamine. Z. Naturforsch. B 19:862–64 [Google Scholar]
110. Friedrich-Freksa H, Papadopulu G, Gössner W. 1969. Histochemische untersuchungen der cancerogenese in der rattenleber nach zeitlich begrenzter verabfolgung von diäthylnitrosamin. Z. Krebsforsch. 72:240–53 [Google Scholar]
111. Solt D, Farber E. 1976. New principle for the analysis of chemical carcinogenesis. Nature 263:701–3 [Google Scholar]
112. Berenblum I, Shubik P. 1947. A new, quantitative, approach to the study of stages of chemical carcinogenesis in the mouse's skin. Br. J. Cancer 1:383–91 [Google Scholar]
113. Berenblum I, Shubik P. 1949. The persistence of latent tumor cells induced in the mouse's skin by a single application of 9,10-dimethyl-1,2-benzanthracene. Br. J. Cancer 3:384–86 [Google Scholar]
114. Boutwell RK. 1964. Some biological aspects of skin carcinogenesis. Prog. Exp. Tumor Res. 4:207–50 [Google Scholar]
115. Campbell HA, Xu YD, Hanigan MH, Pitot HC. 1986. Application of quantitative stereology to the evaluation of phenotypically heterogeneous enzyme-altered foci in the rat liver. J. Natl. Cancer Inst. 76:751–67Quantitation of numbers and value occupied by each of several phenotypes of AHF was accomplished by a unique logic involving quantitative stereology. [Google Scholar]
116. Xu YH, Pitot HC. 2003. An improved stereologic method for three-dimensional estimation of particle size distribution from observations in two dimensions and its application. Comput. Methods Programs Biomed. 72:1–20 [Google Scholar]
117. Peraino C, Staffeldt EF, Carnes BA, Ludeman VA, Blomquist JA, Vesselinovitch SD. 1984. Characterization of histochemically detectable altered hepatocyte foci and their relationship to hepatic tumorigenesis in rats treated once with diethylnitrosamine or benzo(a)pyrene within one day after birth. Cancer Res. 44:3340–47 [Google Scholar]
118. Hendrich S, Campbell HA, Pitot HC. 1987. Quantitative stereological evaluation of four histochemical markers of altered foci in multistage hepatocarcinogenesis in the rat. Carcinogenesis 8:1245–50 [Google Scholar]
119. Tatematsu M, Mera Y, Ito N, Satoh K, Sato K. 1985. Relative merits of immunohistochemical demonstrations of placental, A, B and C forms of glutathione S-transferase and histochemical demonstration of gamma-glutamyl transferase as markers of altered foci during liver carcinogenesis in rats. Carcinogenesis 6:1621–26 [Google Scholar]
120. Rao MS, Nemali MR, Usuda N, Scarpelli DG, Makino T. et al. 1988. Lack of expression of glutathione-S-transferase P, γ-glutamyl transpeptidase, and α-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferators. Cancer Res. 48:4919–25 [Google Scholar]
121. Glauert HP, Beer D, Rao MS, Schwarz M, Xu YD. et al. 1986. Induction of altered hepatic foci in rats by the administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethylnitrosamine. Cancer Res. 46:4601–6 [Google Scholar]
122. Hendrich S, Glauert HP, Pitot HC. 1986. The phenotypic stability of altered hepatic foci: effects of withdrawal and subsequent readministration of phenobarbital. Carcinogenesis 7:2041–45 [Google Scholar]
123. Iversen OH. 1982. Hairless mouse skin in two-stage chemical carcinogenesis. Virchows Archiv. B Cell Pathol. 38:263–72 [Google Scholar]
124. Boutwell RK. 1964. Some biological aspects of skin carcinogenesis. Prog. Exp. Tumor Res. 4:207–50 [Google Scholar]
125. Hanigan MH, Pitot HC. 1985. Growth of carcinogen-altered rat hepatocytes in the liver of syngeneic recipients promoted with phenobarbital. Cancer Res. 45:6063–70 [Google Scholar]
126. Kreamer BL, Staecker JL, Sawada N, Sattler GL, Hsia MTS, Pitot HC. 1986. Use of a low-speed iso-density Percoll centrifugation method to increase the viability of isolated rat hepatocyte preparations. In Vitro 22:201–11 [Google Scholar]
127. Goldsworthy TL, Pitot HC. 1985. The quantitative analysis and stability of histochemical markers of altered hepatic foci in rat liver following initiation by diethylnitrosamine administration and promotion with phenobarbital. Carcinogenesis 6:1261–69 [Google Scholar]
128. Williams GM, Watanabe K. 1978. Quantitative kinetics of development of N-2-fluorenylacetamide-induced, altered (hyperplastic) hepatocellular foci resistant to iron accumulation and of their reversion or persistence following removal of carcinogen. J. Natl. Cancer Inst. 61:113–21 [Google Scholar]
129. Takahashi S, Lombardi B, Shinozuka H. 1982. Progression of carcinogen-induced foci of γ-glutamyltranspeptidase-positive hepatocytes to hepatomas in rats fed a choline-deficient diet. Int. J. Cancer 29:445–50 [Google Scholar]
130. Kolaja KL, Stevenson DE, Walborg EF Jr, Klaunig JE. 1996. Reversibility of promoter induced hepatic focal lesion growth in mice. Carcinogenesis 17:1403–9 [Google Scholar]
131. Hikita H, Vaughan J, Pitot HC. 1997. The effect of two periods of short-term fasting during the promotion stage of hepatocarcinogenesis in rats: the role of apoptosis and cell proliferation. Carcinogenesis 18:159–66 [Google Scholar]
132. Schulte-Hermann R, Timmermann-Trosiener I, Barthel G, Bursch W. 1990. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res. 50:5127–35 [Google Scholar]
133. Kolaja KL, Stevenson DE, Johnson JT, Walborg JEF, Klaunig JE. 1996. Subchronic effects of dieldrin and phenobarbital on hepatic DNA synthesis in mice and rats. Fund. Appl. Toxicol. 29:219–28 [Google Scholar]
134. Schulte-Hermann R, Bursch W, Grasl-Kraupp B, Müllauer L, Ruttkay-Nedecky B. 1995. Apoptosis and multistage carcinogenesis in rat liver. Mutat. Res. 333:81–87 [Google Scholar]
135. Pitot HC. 1989. Progression: the terminal stage in carcinogenesis. Jpn. J. Cancer Res. 80:599–607 [Google Scholar]
136. Binder RL, Johnson GR, Gallagher PM, Stockman SL, Sundberg JP, Conti CJ. 1998. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen. Cancer Res. 58:4314–23 [Google Scholar]
137. Pretlow TP, O'Riordan MA, Spancake KM, Pretlow TG. 1993. Two types of putative preneoplastic lesions identified by hexosaminidase activity in whole-mounts of colons from F344 rats treated with carcinogen. Am. J. Pathol. 142:1695–1700 [Google Scholar]
138. Siu IM, Pretlow TG, Amini SB, Pretlow TP. 1997. Identification of dysplasia in human colonic aberrant crypt foci. Am. J. Pathol. 150:1805–13 [Google Scholar]
139. Yuspa SH, Poirier MC. 1988. Chemical carcinogenesis: from animal models to molecular models in one decade. Adv. Cancer Res. 50:25–70 [Google Scholar]
140. Rabes HM. 1983. Development and growth of early preneoplastic lesions induced in the liver by chemical carcinogens. J. Cancer Res. Clin. Oncol. 106:85–92 [Google Scholar]
141. Moore MA, Nakagawa K, Satoh K, Ishikawa T, Sato K. 1987. Single GST-P positive liver cells—putative initiated hepatocytes. Carcinogenesis 8:483–86 [Google Scholar]
142. Pitot HC, Dragan YP, Teeguarden J, Hsia S, Campbell H. 1996. Quantitation of multistage carcinogenesis in rat liver. Toxicol. Pathol. 24:119–28 [Google Scholar]
143. Satoh K, Hatayama I, Tateoka N, Tamai K, Shimizu T. et al. 1989. Transient induction of single GST-P positive hepatocytes by DEN. Carcinogenesis 10:2107–11 [Google Scholar]
144. James J. 1977. The genesis of polyploidy in rat liver parenchymal cells. Cytobiologie 15:410–19 [Google Scholar]
145. Goldsworthy T, Campbell HA, Pitot HC. 1984. The natural history and dose-response characteristics of enzyme-altered foci in rat liver following phenobarbital and diethylnitrosamine administration. Carcinogenesis 5:67–71 [Google Scholar]
146. Tsuda H, Fukushima S, Wanibuchi H, Morimura K, Nakae D. et al. 2003. Value of GST-P positive preneoplastic hepatic foci in dose-response studies of hepatocarcinogenesis: evidence for practical thresholds with both genotoxic and nongenotoxic carcinogens. A review of recent work. Toxicol. Pathol. 31:80–86 [Google Scholar]
147. Dragan YP, Hully JR, Nakamura J, Mass MJ, Swenberg JA, Pitot HC. 1994. Biochemical events during initiation of rat hepatocarcinogenesis. Carcinogenesis 15:1451–58 [Google Scholar]
148. Dragan YP, Peterson J, Pitot HC. 1993. Comparison of hepatocyte phenotypes at the glutathione transferase and albumin loci in Sprague-Dawley and Nagase analbuminemic rats and F1 progeny after initiation and promotion. Carcinogenesis 14:1313–19 [Google Scholar]
149. Tanaka H, Matsuhisa A, Nagamori S, Shimizu K, Niiya M. et al. 1990. Characteristics and significance of albumin-positive hepatocytes in analbuminemic rats. Eur. J. Cell Biol. 53:267–74 [Google Scholar]
150. Hitomi Y, Sugiyama K, Esumi H. 1998. Suppression of the 5′ splice site mutation in the Nagase analbuminemic rat with mutated U1snRNA. Biochem. Biophys. Res. Commun. 251:11–16 [Google Scholar]
151. Ward JM, Henneman JR. 1990. Naturally-occurring age-dependent glutathione S-transferase π immunoreactive hepatocytes in aging female F344 rat liver as potential promotable targets for nongenotoxic carcinogens. Cancer Lett. 52:187–95 [Google Scholar]
152. Neel JV. 1983. Frequency of spontaneous and induced ‘point’ mutations in higher eukaryotes. J. Hered. 74:2–15 [Google Scholar]
153. Popp JA, Scortichini BH, Garvey LK. 1985. Quantitative evaluation of hepatic foci of cellular alteration occurring spontaneously in Fischer-344 rats. Fund. Appl. Toxicol. 5:314–19 [Google Scholar]
154. Foulds L. 1954. The experimental study of tumor progression: a review. Cancer Res. 14:327–39 [Google Scholar]
155. Peraino C, Fry RJM, Staffeldt EF. 1971. Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene. Cancer Res. 31:1506–12 [Google Scholar]
156. Scherer E, Feringa AW, Emmelot P. 1984. Initiation-promotion-initiation. Induction of neoplastic foci within islands of precancerous liver cells in the rat. In Models, Mechanisms and Etiology of Tumour Promotion ed. M Börzsönyi, K Lapis, NE Day, H Yamasaki pp. 57–66 Lyon: Int. Agency Res. Cancer [Google Scholar]
157. Scherer E. 1987. Relationship among histochemically distinguishable early lesions in multistep-multistage hepatocarcinogenesis. Arch. Toxicol. Suppl. 10:81–94 [Google Scholar]
158. Roomi MW, Ho RK, Sarma DSR, Farber E. 1985. A common biochemical pattern in preneoplastic hepatocyte nodules generated in four different models in the rat. Cancer Res. 45:564–71 [Google Scholar]
159. Eriksson LC, Blanck A, Bock KW, Mannervik B. 1987. Metabolism of xenobiotics in hepatocyte nodules. Toxicol. Pathol. 15:27–42 [Google Scholar]
160. Chen ZY, White CC, Eaton DL. 1993. Decreased expression of cytochrome P450 mRNAs and related steroid hydroxylation activities in hepatic hyperplastic nodules in male F344 rats. Toxicol. Appl. Pharmacol. 123:151–59 [Google Scholar]
161. Potter VR. 1981. A new protocol and its rationale for the study of initiation and promotion of carcinogenesis in rat liver. Carcinogenesis 2:1375–79 [Google Scholar]
162. Moolgavkar SH. 1986. Carcinogenesis modeling: from molecular biology to epidemiology. Annu. Rev. Public Health 7:151–69 [Google Scholar]
163. Steinmetz KL, Klaunig JE. 1996. Transforming growth factor-α in carcinogen-induced F344 rat hepatic foci. Toxicol. Appl. Pharmacol. 140:131–45 [Google Scholar]
164. Moser GJ, Wolf DG, Goldsworthy TL. 1997. Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver. Toxicol. Pathol. 25:275–83 [Google Scholar]
165. Dragan Y, Teeguarden J, Campbell H, Hsia S, Pitot HC. 1995. The quantitation of altered hepatic foci during multistage hepatocarcinogenesis in the rat: transforming growth factor α expression as a marker for the stage of progression. Cancer Lett. 93:73–83 [Google Scholar]
166. Dragan YP, Sargent L, Xu YD, Xu Y, Pitot HC. 1993. The initiation-promotion-progression model of rat hepatocarcinogenesis. Proc. Soc. Exp. Biol. Med. 202:16–24IPP protocol classifies agents by their action at one or a combination of the stages of initiation, promotion, and progression. [Google Scholar]
167. Pitot HC, Dragan YP. 1993. Stage of tumor progression, progressor agents, and human risk. Proc. Soc. Exp. Biol. Med. 202:37–43 [Google Scholar]
168. Dragan YP, Fahey S, Street K, Vaughan J, Jordan VC, Pitot HC. 1994. Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 rats. Breast Cancer Res. Treat. 31:11–25 [Google Scholar]
169. Sargent LM, Dragan YP, Bahnub N, Wiley JE, Sattler CA. et al. 1994. Tamoxifen induces hepatic aneuploidy and mitotic spindle disruption after a single in vivo administration to female Sprague-Dawley rats. Cancer Res. 54:3357–60 [Google Scholar]
170. Sargent L, Xu YH, Sattler GL, Meisner L, Pitot HC. 1989. Ploidy and karyotype of hepatocytes isolated from enzyme-altered foci in two different protocols of multistage hepatocarcinogenesis in the rat. Carcinogenesis 10:387–91No visible chromosomal breakage occurred in cells of AHF in the stage of promotion, but hepatotoxicity resulted in AHF with marked chromosomal breakage. [Google Scholar]
171. Sargent L, Dragan Y, Xu YH, Sattler G, Wiley J, Pitot HC. 1996. Karyotypic changes in a multistage model of chemical hepatocarcinogenesis in the rat. Cancer Res. 56:2985–91 [Google Scholar]
172. Pitot HC, Dragan YP. 1994. The multistage nature of chemically induced hepatocarcinogenesis in the rat. Drug Metabol. Rev. 26:209–20 [Google Scholar]
173. Sargent L, Dragan YP, Babcock K, Wiley J, Klaunig J, Pitot HC. 1996. Cytogenetic analysis of three rat liver epithelial cell lines (WBneo, WBHa-ras, and WBrasIIa) and correlation of an early chromosomal alteration with insulin-like growth factor II expression. Cancer Res. 56:2992–97 [Google Scholar]
174. Sargent LM, Dragan YP, Sattler G, Xu YH, Wiley J, Pitot HC. 1997. Specific chromosomal changes in albumin simian virus 40 T antigen transgenic rat liver neoplasms. Cancer Res. 57:3451–56Earliest spontaneous chromosomal alteration in livers of small alb SV40 T Ag transgenic rats occurs in a duplication of the long arm of chromosome 1. [Google Scholar]
175. Dragan YP, Sargent LM, Babcock K, Kinunen N, Pitot HC. 2004. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats. Mol. Carcinog. 40:150–59 [Google Scholar]
176. Bartolemi MS, Tilghman SM. 1997. Genomic imprinting in mammals. Annu. Rev. Genet. 31:493–525 [Google Scholar]
177. Steinmetz KL, Pogribny IP, James SJ, Pitot HC. 1998. Hypomethylation of the rat glutathione-S-transferase π (GSTP) promoter region isolated from methyl-deficient livers and GSTP-positive liver neoplasms. Carcinogenesis 19:1487–94Five CpG sites within consensus sequences for DNA binding proteins in the promoter region of GSTP are methylated in liver, but not in preneoplastic and neoplastic liver. [Google Scholar]
178. Lee S, Lee HJ, Kim JH, Lee HS, Jang JJ, Kang GH. 2003. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am. J. Pathol. 163:1371–78 [Google Scholar]
179. Simile MM, Pascale R, De Miglio MR, Nufris A, Daino L. et al. 1994. Correlation between S-adenosyl-L-methionine content and production of c-myc, c-HA-ras, and c-Ki-ras mRNA transcripts in the early stages of rat liver carcinogenesis. Cancer Lett. 79:9–16 [Google Scholar]
180. Makos M, Nelkin BD, Reiter RE, Gnarra JR, Brooks J. et al. 1993. Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors. Cancer Res. 53:2719–22 [Google Scholar]
181. Vuillemenot BR, Pulling LC, Palmisano WA, Hutt JA, Belinsky SA. 2004. Carcinogen exposure differentially modulates RAR-β promoter hypermethylation, an early and frequent event in mouse lung carcinogenesis. Carcinogenesis 25:623–29 [Google Scholar]
182. Manoharan H, Babcock K, Pitot HC. 2004. Changes in the DNA methylation profile of the rat H19 gene upstream region during development and transgenic hepatocarcinogenesis and its role in the imprinted transcriptional regulation of the H19 gene. Mol. Carcinog. 41:1–16 [Google Scholar]
183. Pitot HC. 1993. Multistage carcinogenesis—genetic and epigenetic mechanisms in relation to cancer prevention. Cancer Detect. Prevent. 17:567–73 [Google Scholar]